Media coverage
1
Media coverage
Title Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Di Media name/outlet Clinical Trials.gov Date 2/10/18 Persons Diego Luis Saaibi Solano